A study investigates the links between fine-scale populations and outcomes including healthcare use and disease risk in a Los Angeles biobank, unveiling crucial insights into healthcare disparities in the USA.
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1038%2Fs41591-023-02423-3/MediaObjects/41591_2023_2423_Fig1_HTML.png)
References
Caggiano, C. et al. Nat. Med. https://doi.org/10.1038/s41591-023-02425-1 (2023).
The SIGMA Type 2 Diabetes Consortium. Nature 506, 97–101 (2014).
The SIGMA Type 2 Diabetes Consortium. JAMA 311, 2305–2314 (2014).
Jbaily, A. et al. Nature 601, 228–233 (2022).
Martin, A. R. et al. C. Nat. Genet. 51, 584–591 (2019).
Belbin, G. M. et al. Cell 184, 2068–2083.e11 (2021).
Johnson, R. et al. Cell Genom. 3, 100243 (2023).
Vyas, D. A., Eisenstein, L. G. & Jones, D. S. N. Engl. J. Med. 383, 874–882 (2020).
Borrell, L. N. et al. N. Engl. J. Med. 384, 474–480 (2021).
The All of Us Research Program Investigators. N. Engl. J. Med. 381, 668–676 (2019).
Claw, K. G. et al. Nat. Commun. 9, 2957 (2018).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The author declares no competing interests.
Rights and permissions
About this article
Cite this article
Kanai, M. Leveraging fine-scale population structures for precision healthcare. Nat Med 29, 1611–1612 (2023). https://doi.org/10.1038/s41591-023-02423-3
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41591-023-02423-3
- Springer Nature America, Inc.
This article is cited by
-
Building healthy populations
Nature Medicine (2023)